ArticleBlood2013

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

Joshua J Field et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.